Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice
Open Access
- 1 July 2003
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 8 (1) , 80-89
- https://doi.org/10.1016/s1525-0016(03)00129-1
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002
- Designing gene therapy vectors: avoiding immune responses by using tissue-specific promotersGene Therapy, 2001
- Helper (CD4+) and Cytotoxic (CD8+) T Cells Promote the Pathology of Dystrophin-Deficient MuscleClinical Immunology, 2001
- Analysis of Muscle Creatine Kinase Regulatory Elements in Recombinant Adenoviral VectorsMolecular Therapy, 2000
- Massive Idiosyncratic Exon Skipping Corrects the Nonsense Mutation in Dystrophic Mouse Muscle and Produces Functional Revertant Fibers by Clonal ExpansionThe Journal of cell biology, 2000
- Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?Neuromuscular Disorders, 1997
- In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral GenesHuman Gene Therapy, 1996
- MdxTransgenic Mouse: Restoration of Recombinant Dystrophin to the Dystrophic MuscleHuman Gene Therapy, 1993
- Profiles of creatine kinase isoenzyme compositions in single muscle fibres of different typesJournal of Muscle Research and Cell Motility, 1991
- Effect of denervation on the distribution and developmental transition of phosphoglycerate mutase and creatine phosphokinase isozymes in rat muscles of different fiber-type compositionDifferentiation, 1990